BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22412958)

  • 1. Time course and pattern of metastasis of cutaneous melanoma differ between men and women.
    Mervic L
    PLoS One; 2012; 7(3):e32955. PubMed ID: 22412958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
    Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
    Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: risk factors and prognostic impact.
    Kretschmer L; Preusser KP; Neumann C
    Melanoma Res; 2002 Oct; 12(5):499-504. PubMed ID: 12394192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
    Eggermont AMM; Blank CU; Mandalà M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C;
    Lancet Oncol; 2021 May; 22(5):643-654. PubMed ID: 33857412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival.
    Vallet A; Oriano B; Mortier L; Dalle S; Dutriaux C; Guillot B; Leccia MT; Dalac S; Saiag P; Lacour JP; Legoupil D; De Quatrebarbes J; Brunet-Possenti F; Lesimple T; Arnault JP; Aubin F; Granel-Brocard F; Stoebner PE; Maubec E; Dreno B; Allayous C; Porcher R; Lebbé C;
    JAMA Dermatol; 2019 Jun; 155(6):673-678. PubMed ID: 31042256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
    Zaremba A; Philip M; Hassel JC; Glutsch V; Fiocco Z; Loquai C; Rafei-Shamsabadi D; Gutzmer R; Utikal J; Haferkamp S; Reinhardt L; Kähler KC; Weishaupt C; Moreira A; Thoms KM; Wilhelm T; Pföhler C; Roesch A; Ugurel S; Zimmer L; Stadtler N; Sucker A; Kiecker F; Heinzerling L; Meier F; Meiss F; Schlaak M; Schilling B; Horn S; Schadendorf D; Livingstone E
    Eur J Cancer; 2021 Jul; 152():139-154. PubMed ID: 34102453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rational approach to the follow-up of melanoma patients.
    Garbe C
    Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
    Pawlik TM; Ross MI; Johnson MM; Schacherer CW; McClain DM; Mansfield PF; Lee JE; Cormier JN; Gershenwald JE
    Ann Surg Oncol; 2005 Aug; 12(8):587-96. PubMed ID: 16021533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.
    Weide B; Faller C; Büttner P; Pflugfelder A; Leiter U; Eigentler TK; Bauer J; Forschner A; Meier F; Garbe C
    PLoS One; 2013; 8(4):e63137. PubMed ID: 23638183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
    Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
    Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.
    Meyer T; Merkel S; Göhl J; Hohenberger W
    Eur J Surg Oncol; 2002 Jun; 28(4):424-30. PubMed ID: 12099654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival with regional and distant metastases from cutaneous malignant melanoma.
    Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
    Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
    Tas F; Erturk K
    Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural course of cutaneous melanoma.
    Leiter U; Meier F; Schittek B; Garbe C
    J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in young women with cutaneous melanoma.
    Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
    Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.